- Home
- CRGX vs JKS Comparison
CRGX vs JKS Comparison
Compare CRGX & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- JKS
- Stock Information
- Founded
- CRGX 2021
- JKS 2006
- Country
- CRGX United States
- JKS China
- Employees
- CRGX N/A
- JKS N/A
- Industry
- CRGX
- JKS Semiconductors
- Sector
- CRGX
- JKS Technology
- Exchange
- CRGX Nasdaq
- JKS Nasdaq
- Market Cap
- CRGX 964.5M
- JKS 954.7M
- IPO Year
- CRGX 2023
- JKS 2010
- Fundamental
- Price
- CRGX $16.00
- JKS $20.91
- Analyst Decision
- CRGX Strong Buy
- JKS Sell
- Analyst Count
- CRGX 7
- JKS 6
- Target Price
- CRGX $30.33
- JKS $22.46
- AVG Volume (30 Days)
- CRGX 167.8K
- JKS 2.1M
- Earning Date
- CRGX 11-12-2024
- JKS 10-30-2024
- Dividend Yield
- CRGX N/A
- JKS 7.17%
- EPS Growth
- CRGX N/A
- JKS N/A
- EPS
- CRGX N/A
- JKS 0.89
- Revenue
- CRGX N/A
- JKS $14,888,551,409.00
- Revenue This Year
- CRGX N/A
- JKS N/A
- Revenue Next Year
- CRGX N/A
- JKS $6.64
- P/E Ratio
- CRGX N/A
- JKS $23.62
- Revenue Growth
- CRGX N/A
- JKS N/A
- 52 Week Low
- CRGX $13.56
- JKS $16.70
- 52 Week High
- CRGX $33.92
- JKS $38.37
- Technical
- Relative Strength Index (RSI)
- CRGX 32.69
- JKS 42.04
- Support Level
- CRGX $19.96
- JKS $20.50
- Resistance Level
- CRGX $23.00
- JKS $22.15
- Average True Range (ATR)
- CRGX 1.79
- JKS 1.58
- MACD
- CRGX -0.58
- JKS -0.60
- Stochastic Oscillator
- CRGX 7.04
- JKS 4.86
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific (except China, which includes Hong Kong and Taiwan), and the Rest of the world.